Health ❯Research ❯Clinical Trials

Drug Development

Future Prospects Mitochondrial Medicine Alzheimer's Drug RI-AG03 Cancer Therapies Innovative Therapies Nitisinone Trials Gerontology Kinase Inhibitors

MLi-2 Kinase Inhibitor Fully Restores Neuronal Cilia and Promotes Recovery in a Parkinson’s Mouse Model

The preclinical success supports multiple ongoing LRRK2 inhibitor trials, suggesting that the approach could extend to non-genetic Parkinson’s.

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials

Nitisinone Advances as Promising Malaria Control Tool

Caterpillar Fungus Shows Promise in Cancer Treatment

Breakthrough Alzheimer's Drug Targets Key Tau Protein Hotspots